Partnerships and Industry
The Monash Centre to Impact Antimicrobial Resistance works with industry, government and other organisations, through funded collaborative research and provision of contract research services.
Our research partnerships draw on the Centre’s interdisciplinary expertise network of its 25 world-leading research leaders and the research capability provided by the Centre’s Antimicrobial Resistance R&D Facility. This enables our partners to work with us at all stages of the R&D pipeline, from understanding the fundamental biology of Antimicrobial resistance to engineering new detection methods and changing public thinking about AMR.
Beating the superbugs - A Different Lens production
Meet Monash researchers and sepsis survivor Mandy McCracken, who talk about the impact of superbug infections.
Monash researchers are responding to the global call for new solutions to drug-resistant infections. From drug discovery, rethinking current therapeutics to investigating the potential of Phage Therapy.
Mandy McCracken was hospitalised in 2013 with a Group A Streptococcal infection that led to sepsis and ultimately the loss of all her limbs.
Click the LINK Below